ARMK Form 4: COO exercises options, net sell-to-cover of shares
Rhea-AI Filing Summary
Aramark (ARMK) reporting person: Marc A. Bruno, COO, U.S. Food & Facilities, completed option-related transactions on 08/14/2025. He exercised stock options with a $23.55 exercise price for 49,793 shares and, in a net exercise, disposed of 35,160 shares to cover the exercise price and tax withholding. The filings show 49,793 shares acquired via exercise and 35,160 shares sold at $39.60. Beneficial ownership moved from 259,023.226 shares after the sale to 294,183.226 shares following the acquisition entry in the filing sequence. The options exercised are fully vested and expire on 11/20/2025.
Positive
- Options fully vested: The exercised options are reported as fully vested, providing clarity on exercisability.
- Net ownership increase: After the transactions the reporting person is shown with 294,183.226 shares beneficially owned.
Negative
- Partial sale of shares: 35,160 shares were disposed of at $39.60 to cover exercise price and tax withholding.
- Near-term option expiry: The exercised options expire on 11/20/2025, indicating limited remaining duration for these instruments.
Insights
TL;DR: Insider exercised vested options and sold a portion to cover costs, modest net increase in holdings.
The filing documents a routine net exercise of stock options by a senior officer that resulted in 49,793 shares exercised at a $23.55 strike and 35,160 shares disposed of at $39.60 to satisfy exercise price and tax withholding. The reporting person retains options that expire 11/20/2025 and ends with a recorded beneficial ownership of 294,183.226 shares per the filing. This is a common liquidity management action by insiders and does not, by itself, indicate a change in company fundamentals.
TL;DR: Transaction appears procedurally compliant; disclosures show vested options and standard withholding sale.
The Form 4 discloses a net exercise and associated sell-to-cover transaction documented with dates, prices, and the expiration of the underlying options. The filing is signed by an attorney-in-fact and includes the required explanatory note that the options are fully vested and expire on 11/20/2025. From a governance standpoint, the disclosure is timely and contains the necessary details for investor review.